552 research outputs found

    Disruption of Drosophila melanogaster Lipid Metabolism Genes Causes Tissue Overgrowth Associated with Altered Developmental Signaling.

    Get PDF
    Developmental patterning requires the precise interplay of numerous intercellular signaling pathways to ensure that cells are properly specified during tissue formation and organogenesis. The spatiotemporal function of many developmental pathways is strongly influenced by the biosynthesis and intracellular trafficking of signaling components. Receptors and ligands must be trafficked to the cell surface where they interact, and their subsequent endocytic internalization and endosomal trafficking is critical for both signal propagation and its down-modulation. In a forward genetic screen for mutations that alter intracellular Notch receptor trafficking in Drosophila melanogaster, we recovered mutants that disrupt genes encoding serine palmitoyltransferase and acetyl-CoA carboxylase. Both mutants cause Notch, Wingless, the Epidermal Growth Factor Receptor (EFGR), and Patched to accumulate abnormally in endosomal compartments. In mosaic animals, mutant tissues exhibit an unusual non-cell-autonomous effect whereby mutant cells are functionally rescued by secreted activities emanating from adjacent wildtype tissue. Strikingly, both mutants display prominent tissue overgrowth phenotypes that are partially attributable to altered Notch and Wnt signaling. Our analysis of the mutants demonstrates genetic links between abnormal lipid metabolism, perturbations in developmental signaling, and aberrant cell proliferation

    Prevention and Regression of Chronic Kidney Disease and Hypertension

    Get PDF

    Withdrawal of antihypertensive medication: a systematic review

    Get PDF
    Although antihypertensive medication is usually continued indefinitely, observations during wash-out phases in hypertension trials have shown that withdrawal of antihypertensive medication might be well tolerated to do in a considerable proportion of people. A systematic review was completed to determine the proportion of people remaining normotensive for 6 months or longer after cessation of antihypertensive therapy and to investigate the safety of withdrawal. The mean proportion adjusted for sample size of people remaining below each study's threshold for hypertension treatment was 0.38 at 6 months [95% confidence interval (CI) 0.37–0.49; 912 participants], 0.40 at 1 year (95% CI 0.40–0.40; 2640 participants) and 0.26 at 2 years or longer (95% CI 0.26–0.27; 1262 participants). Monotherapy, lower blood pressure before withdrawal and body weight were reported as predictors for successful withdrawal. Adverse events were more common in those who withdrew but were minor and included headache, joint pain, palpitations, oedema and a general feeling of being unwell. Prescribers should consider offering patients with well controlled hypertension a trial of withdrawal of antihypertensive treatment with subsequent regular blood pressure monitoring

    Reply to Visit‐to‐Visit Blood Pressure Variation: Time to Reanalyze All The Data From the TROPHY Study

    Full text link
    Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/97448/1/jch12069.pd

    Lipid metabolic perturbation is an early-onset phenotype in adult spinster mutants: a Drosophila model for lysosomal storage disorders

    Get PDF
    Intracellular accumulation of lipids and swollen dysfunctional lysosomes are linked to several neurodegenerative diseases, including lysosomal storage disorders (LSD). Detailed characterization of lipid metabolic changes in relation to the onset and progression of neurodegeneration is currently missing. We systematically analyzed lipid perturbations in spinster (spin) mutants, a Drosophila model of LSD-like neurodegeneration. Our results highlight an imbalance in brain ceramide and sphingosine in the early stages of neurodegeneration, preceding the accumulation of endomembranous structures, manifestation of altered behavior, and buildup of lipofuscin. Manipulating levels of ceramidase and altering these lipids in spin mutants allowed us to conclude that ceramide homeostasis is the driving force in disease progression and is integral to spin function in the adult nervous system. We identified 29 novel physical interaction partners of Spin and focused on the lipid carrier protein, Lipophorin (Lpp). A subset of Lpp and Spin colocalize in the brain and within organs specialized for lipid metabolism (fat bodies and oenocytes). Reduced Lpp protein was observed in spin mutant tissues. Finally, increased levels of lipid metabolites produced by oenocytes in spin mutants allude to a functional interaction between Spin and Lpp, underscoring the systemic nature of lipid perturbation in LSD

    Simultaneous Detection of [metal(II)-tpen]^<2+> as Kinetically Inert Cationic Complexes Using Pre-capillary Derivatization Electrophoresis: An Application to Biological Samples

    Get PDF
    A high resolution of doubly charged first row transition (Fe, Cu, Zn, Ni, Co, Mn) and heavy metal (Pb, Cd, Hg) ions was achieved in capillary electrophoresis (CE) with high sensitivity (sub-micromol dm^ level), using NN,N'N'-tetrakis(2-pyridylmethyl)ethylenediamine ( TPEN) as a pre-capillary derivatizing agent. The non-charged reagent, TPEN, was applied to capillary zone electrophoresis (CZE) for the first time. Since complete spatial separation between the complexes and the ligand was carried out in a carrier buffer, which was free of TPEN, kinetic inertness of metal complexes was necessary for the detection in this pre-capillary method. All the nine listed metal complexes were detected: Ca^, Mg^, Al^, Fe^, and Co^ complexes were undetectable. This, interestingly, suggests that those nine cations form kinetically inert tpen complexes without strong charge-charge interactions between the metal ion and the ligand. It is expected that the hard-soft-acid-base ( HSAB) principle governed the kinetics selectivity. With respect to the electrophoretic behavior, the addition of chloride ion and methanol to the carrier significantly improved the resolution. This is due to the formation of ternary complexes or ion aggregates and the solvation effect, respectively. These effects provided a satisfactory baseline resolution among the nine metal ions. An application to biological samples was demonstrated. Some metal ions in human serum and urine were successfully detected in a simple process without the need for deproteinization using a non-coated fused-silica capillary because of the differenciation in the direction of migration between organic matter and complexes.http://www.rsc.org/publishing/journals/AN/article.asp?doi=b417394etextapplication/pdfjournal articl

    Iodate respiration by Azoarcus sp. DN11 and its potential use for removal of radioiodine from contaminated aquifers

    Get PDF
    Azoarcus sp. DN11 was previously isolated from gasoline-contaminated groundwater as an anaerobic benzene-degrading bacterium. Genome analysis of strain DN11 revealed that it contained a putative idr gene cluster (idrABP1P2), which was recently found to be involved in bacterial iodate (IO3−) respiration. In this study, we determined if strain DN11 performed iodate respiration and assessed its potential use to remove and sequester radioactive iodine (129I) from subsurface contaminated aquifers. Strain DN11 coupled acetate oxidation to iodate reduction and grew anaerobically with iodate as the sole electron acceptor. The respiratory iodate reductase (Idr) activity of strain DN11 was visualized on non-denaturing gel electrophoresis, and liquid chromatography–tandem mass spectrometry analysis of the active band suggested the involvement of IdrA, IdrP1, and IdrP2 in iodate respiration. The transcriptomic analysis also showed that idrA, idrP1, and idrP2 expression was upregulated under iodate-respiring conditions. After the growth of strain DN11 on iodate, silver-impregnated zeolite was added to the spent medium to remove iodide from the aqueous phase. In the presence of 200 μM iodate as the electron acceptor, more than 98% of iodine was successfully removed from the aqueous phase. These results suggest that strain DN11 is potentially helpful for bioaugmentation of 129I-contaminated subsurface aquifers

    Increased expression of vascular endothelin type B and angiotensin type 1 receptors in patients with ischemic heart disease

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Endothelin-1 and angiotensin II are strong vasoconstrictors. Patients with ischemic heart disease have elevated plasma levels of endothelin-1 and angiotensin II and show increased vascular tone. The aim of the present study was to examine the endothelin and angiotensin II receptor expression in subcutaneous arteries from patients with different degrees of ischemic heart disease.</p> <p>Methods</p> <p>Subcutaneous arteries were obtained, by biopsy from the abdomen, from patients undergoing coronary artery bypass graft (CABG) surgery because of ischemic heart disease (n = 15), patients with angina pectoris without established myocardial infarction (n = 15) and matched cardiovascular healthy controls (n = 15). Endothelin type A (ET<sub>A</sub>) and type B (ET<sub>B</sub>), and angiotensin type 1 (AT<sub>1</sub>) and type 2 (AT<sub>2</sub>) receptors expression and function were examined using immunohistochemistry, Western blot and <it>in vitro </it>pharmacology.</p> <p>Results</p> <p>ET<sub>A </sub>and, to a lesser extent, ET<sub>B </sub>receptor staining was observed in the healthy vascular smooth muscle cells. The level of ET<sub>B </sub>receptor expression was higher in patients undergoing CABG surgery (250% ± 23%; P < 0.05) and in the patients with angina pectoris (199% ± 6%; P < 0.05), than in the healthy controls (100% ± 28%). The data was confirmed by Western blotting. Arteries from CABG patients showed increased vasoconstriction upon administration of the selective ET<sub>B </sub>receptor agonist sarafotoxin S6c, compared to healthy controls (P < 0.05). No such difference was found for the ET<sub>A </sub>receptors. AT<sub>1 </sub>and, to a lesser extent, AT<sub>2 </sub>receptor immunostaining was seen in the vascular smooth muscle cells. The level of AT<sub>1 </sub>receptor expression was higher in both the angina pectoris (128% ± 25%; P < 0.05) and in the CABG patients (203% ± 41%; P < 0.05), as compared to the healthy controls (100% ± 25%). The increased AT<sub>1 </sub>receptor expression was confirmed by Western blotting. Myograph experiment did however not show any change in vasoconstriction to angiotensin II in CABG patients compared to healthy controls (P = n.s).</p> <p>Conclusion</p> <p>The results demonstrate, for the first time, upregulation of ET<sub>B </sub>and AT<sub>1 </sub>receptors in vascular smooth muscle cells in ischemic heart disease. These receptors may play a role in the pathophysiology of ischemic heart disease and could provide important targets for pharmaceutical interventions.</p
    corecore